• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Whistleblower alleges fraud at Florida imaging centers

Article

A Florida radiologist has been named as a defendant in a whistleblower lawsuit alleging Medicare fraud through improper lease arrangements, kickbacks, and upcoding.

A Florida radiologist has been named as a defendant in a whistleblower lawsuit alleging Medicare fraud through improper lease arrangements, kickbacks, and upcoding.

The lawsuit was brought against Dr. Fred L. Steinberg, a radiologist who operates three MR imaging facilities in the Boca Raton area. Dr. David A. Clayman, a neuroradiologist, filed the suit, claiming he was terminated the same day he confronted Steinberg about coding standards.

A spokesperson for Steinberg said that the allegations in the complaint are just that, allegations, and nothing more.

The complaint against Steinberg falls under the federal False Claims Act and could result in fines between $5000 and $11,000 for each claim. The False Claims Act also entitles Clayman to a share ranging from 15% to 30% of any recovery.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.